Literature DB >> 6847695

Structure-activity relationship of ligands of the pyrimidine nucleoside phosphorylases.

J G Niedzwicki, M H el Kouni, S H Chu, S Cha.   

Abstract

Eighty-seven pyrimidine base and nucleoside analogs were evaluated as inhibitors of uridine phosphorylase (UrdPase) and thymidine phosphorylase (dThdPase). These findings, together with an extensive literature review, have allowed construction of structure-activity relationships for the binding of ligands to UrdPase and dThdPase and provide a basis for the rational design of new inhibitors of these enzymes. Additionally, 2,6-pyridinediol and 6-benzyl-2-thiouracil have been identified as being potent inhibitors of UrdPase and dThdPase respectively.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6847695     DOI: 10.1016/0006-2952(83)90517-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

1.  Dynamic metabolic labeling of DNA in vivo with arabinosyl nucleosides.

Authors:  Anne B Neef; Nathan W Luedtke
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

2.  Modification of uridine phosphorylase from Escherichia coli by diethyl pyrocarbonate. Evidence for a histidine residue in the active site of the enzyme.

Authors:  A K Drabikowska; G Woźniak
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

Review 3.  Structural analyses reveal two distinct families of nucleoside phosphorylases.

Authors:  Matthew J Pugmire; Steven E Ealick
Journal:  Biochem J       Date:  2002-01-01       Impact factor: 3.857

4.  Pharmacology and pharmacokinetics of the antiviral agent beta-D-2',3'-dideoxy-3'-oxa-5-fluorocytidine in cells and rhesus monkeys.

Authors:  Brenda I Hernandez-Santiago; Huachun Chen; Ghazia Asif; Thierry Beltran; Shuli Mao; Selwyn J Hurwitz; Jason Grier; Harold M McClure; Chung K Chu; Dennis C Liotta; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

5.  Uridine-induced hypothermia in mice and rats in relation to plasma and tissue levels of uridine and its metabolites.

Authors:  G J Peters; C J van Groeningen; E J Laurensse; J Lankelma; A Leyva; H M Pinedo
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

6.  Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virus.

Authors:  L W Frick; L St John; L C Taylor; G R Painter; P A Furman; D C Liotta; E S Furfine; D J Nelson
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

7.  Inhibition of intestinal pyrimidine nucleoside phosphorylases.

Authors:  M G Wientjes; J L Au
Journal:  Pharm Res       Date:  1987-10       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.